Botto F, Seree E, el Khyari S, Cau P, Henric A, De Meo M, Bergeron P, Barra Y
EA878: Laboratoire de biologie moléculaire appliquée au médicament, Marseille, France.
Biochem Biophys Res Commun. 1994 Dec 15;205(2):1086-92. doi: 10.1006/bbrc.1994.2777.
We have demonstrated the presence of CYP2E1 protein in a catalytically active form in lung tumors, differences being observed between the tumors and normal tissues from the same patients. Indeed, a higher microsomal CYP2E1 N-nitrosodimethylamine (NDMA) demethylase activity was present in normal tissues compared to tumors and was accompanied by corresponding change in CYP2E1 protein concentration, as shown by Western blot analysis. The catalytic activity among tumors differed from that among normal tissues with statistical significance of p < 0.01. CYP2E1 mRNA was present in lung tumors and less expressed compared to normal tissues from the same individuals. In order to understand the regulation of CYP2E1 gene expression, we studied the methylation status of the CYP2E1 gene in human lung tumors and normal tissues from the same patients and observed that a hypomethylation was associated with a hypoexpression of the CYP2E1 gene in lung tumors.
我们已经证实在肺肿瘤中存在具有催化活性形式的CYP2E1蛋白,在同一患者的肿瘤组织和正常组织之间观察到了差异。实际上,与肿瘤组织相比,正常组织中存在更高的微粒体CYP2E1 N-亚硝基二甲胺(NDMA)脱甲基酶活性,并且伴随着CYP2E1蛋白浓度的相应变化,如蛋白质印迹分析所示。肿瘤之间的催化活性与正常组织之间的催化活性不同,具有统计学意义(p < 0.01)。CYP2E1 mRNA存在于肺肿瘤中,与同一患者的正常组织相比表达较少。为了了解CYP2E1基因表达的调控,我们研究了同一患者的人肺肿瘤和正常组织中CYP2E1基因的甲基化状态,观察到低甲基化与肺肿瘤中CYP2E1基因的低表达相关。